{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:44:12Z","timestamp":1783579452024,"version":"3.55.0"},"reference-count":222,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Society for the Promotion of Research in Experimental Neurology, Vienna, Austria"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Dementia with Lewy bodies (DLB), the second common primary degenerative neurocognitive disorder after Alzheimer disease (AD), frequently presents concurrent co-pathologies that impact clinical presentation and progression. Neuropathological studies have demonstrated a high prevalence of coexistent AD-related neuropathological changes (ADNC), TAR DNA-binding protein 43 (TDP-43) proteinopathies, and cardiac and aging-related disorders, while frontotemporal lobar degeneration (FTLD) and tau-related syndromes play a minor role as DLB-related co-pathologies. Cerebrovascular lesions, including cerebral amyloid angiopathy, are the most prevalent non-neurodegenerative co-pathologies. Cardiovascular disorders, hypertension, and hyperlipidemia are also frequent comorbidities. Due to their high prevalence and clinical impact on DLB patients, clinical trials should account for these and other co-pathologies in their design and selection. Evaluation of these co-pathologies using and interpreting biomarkers may allow greater clinical diagnostic accuracy and the opportunity to better predict clinical progression. Therefore, there is an increasing need for biomarkers in dementia research. This review discusses the kind and frequency of the different co-pathologies in DLB and their clinical impact. It evaluates the possible value of disease-specific biomarkers and how they are helpful in the assessment and prevention of DLB and its co-pathologies.<\/jats:p>","DOI":"10.3390\/ijms26167674","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T11:41:53Z","timestamp":1754653313000},"page":"7674","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comorbid Pathologies and Their Impact on Dementia with Lewy Bodies\u2014Current View"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9641-7649","authenticated-orcid":false,"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[{"name":"Institute of Clinical Neurobiology, 1150 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/nan.12648","article-title":"Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson\u2019s disease dementia","volume":"47","author":"Hansen","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jellinger, K.A., and Korczyn, A.D. (2018). Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease?. BMC Med., 16.","DOI":"10.1186\/s12916-018-1016-8"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00702-023-02670-1","article-title":"Mild cognitive impairment in dementia with Lewy bodies: An update and outlook","volume":"130","author":"Jellinger","year":"2023","journal-title":"J. Neural Transm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00702-023-02660-3","article-title":"Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia","volume":"130","author":"Jellinger","year":"2023","journal-title":"J. Neural Transm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord. Off. J. Disord. Soc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1002\/ana.21455","article-title":"Parkinson\u2019s disease dementia: Definitions, guidelines, and research perspectives in diagnosis","volume":"64","author":"Goetz","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3233\/JAD-210006","article-title":"Dissecting the Interplay Between Time of Dementia and Cognitive Profiles in Lewy Body Dementias","volume":"84","author":"Palermo","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Beach, T.G., Serrano, G.E., Zhang, N., Driver-Dunckley, E.D., Sue, L.I., Shill, H.A., Mehta, S.H., Belden, C., Tremblay, C., and Choudhury, P. (2024). Clinicopathological heterogeneity of Lewy body diseases: The profound influence of comorbid Alzheimer\u2019s disease. medRxiv, 2024.08.30.24312864. Available online: https:\/\/www.medrxiv.org\/content\/10.1101\/2024.08.30.24312864v1.","DOI":"10.1101\/2024.08.30.24312864"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41582-025-01090-x","article-title":"Dementia with Lewy bodies and Parkinson disease dementia-the same or different and is it important?","volume":"21","author":"Fu","year":"2025","journal-title":"Nat. Rev. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/alz.12814","article-title":"Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design","volume":"19","author":"Toledo","year":"2022","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","article-title":"Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: A multi-centre study","volume":"141","author":"Attems","year":"2021","journal-title":"Acta Neuropathol."},{"key":"ref_13","first-page":"216","article-title":"Regional Overlap of Pathologies in Lewy Body Disorders","volume":"76","author":"Planellas","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","article-title":"Lewy body dementias","volume":"386","author":"Walker","year":"2015","journal-title":"Lancet"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","article-title":"Interactions of pathological proteins in neurodegenerative diseases","volume":"134","author":"Attems","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.brainres.2007.09.048","article-title":"Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"1184","author":"Higashi","year":"2007","journal-title":"Brain Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bpa.12424","article-title":"TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing","volume":"27","author":"McAleese","year":"2017","journal-title":"Brain Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.parkreldis.2022.11.001","article-title":"Diverse limbic comorbidities cause limbic and temporal atrophy in lewy body disease","volume":"105","author":"Sakurai","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00234-024-03502-z","article-title":"Medial temporal atrophy predicts the limbic comorbidities in lewy body disease","volume":"67","author":"Sakurai","year":"2024","journal-title":"Neuroradiology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","article-title":"Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre","volume":"136","author":"Toledo","year":"2013","journal-title":"Brain"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/ene.15211","article-title":"The influence of cerebrovascular disease in dementia with Lewy bodies and Parkinson\u2019s disease dementia","volume":"29","author":"Hijazi","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s13311-023-01379-z","article-title":"Fluid and Biopsy Based Biomarkers in Parkinson\u2019s Disease","volume":"20","author":"Coughlin","year":"2023","journal-title":"Neurotherapeutics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40035-019-0172-x","article-title":"Beyond the synucleinopathies: Alpha synuclein as a driving force in neurodegenerative comorbidities","volume":"8","author":"Visanji","year":"2019","journal-title":"Transl. Neurodegener."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s41999-022-00727-0","article-title":"Assessment of clinical features and coexisting geriatric syndromes in newly diagnosed dementia with Lewy bodies: A retrospective study in a tertiary geriatrics setting in Turkey","volume":"14","author":"Naharci","year":"2022","journal-title":"Eur. Geriatr. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7631951","DOI":"10.1155\/2018\/7631951","article-title":"Incidence and Comorbidity of Dementia with Lewy Bodies: A Population-Based Cohort Study","volume":"2018","author":"Yang","year":"2018","journal-title":"Behav. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00702-024-02823-w","article-title":"Behavioral disorders in dementia with Lewy bodies: Old and new knowledge","volume":"132","author":"Jellinger","year":"2024","journal-title":"J. Neural Transm."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Jellinger, K.A. (2025). Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26072942"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"148881","DOI":"10.1016\/j.brainres.2024.148881","article-title":"Neuropsychiatric symptoms profile and markers of Alzheimer disease\u2013type pathology in patients with Lewy body dementias","volume":"1833","author":"Geng","year":"2024","journal-title":"Brain Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/ana.26635","article-title":"Concomitant Alzheimer Disease Pathology in Parkinson Disease Dementia","volume":"93","author":"Tropea","year":"2023","journal-title":"Ann. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnen\/nlw070","article-title":"Distribution and Load of Amyloid-\u03b2 Pathology in Parkinson Disease and Dementia with Lewy Bodies","volume":"75","author":"Hepp","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","article-title":"Influence of Alz-heimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies","volume":"60","author":"Merdes","year":"2003","journal-title":"Neurology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-015-1526-9","article-title":"Pathological \u03b1-synuclein distribution in subjects with coincident Alzheimer\u2019s and Lewy body pathology","volume":"131","author":"Toledo","year":"2015","journal-title":"Acta Neuropathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-007-0261-2","article-title":"Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases","volume":"114","author":"Uryu","year":"2007","journal-title":"Acta Neuropathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","article-title":"Phos-phorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"117","author":"Arai","year":"2009","journal-title":"Acta Neuropathol"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ana.25392","article-title":"Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders","volume":"85","author":"Coughlin","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/psyg.12577","article-title":"A case of concomitant dementia with Lewy bodies and argyrophilic grain disease with prominent psychiatric symptoms","volume":"20","author":"Sekine","year":"2020","journal-title":"Psychogeriatrics"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.parkreldis.2015.07.008","article-title":"Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer\u2019s disease","volume":"21","author":"Gungor","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JAD-201495","article-title":"Cerebral Microbleeds in Patients with Parkinson\u2019s Disease and Dementia with Lewy Bodies: Comparison Using Magnetic Resonance Imaging and 99 mTc-ECD SPECT Subtraction Imaging","volume":"80","author":"Takemoto","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/NEN.0b013e3181d88e63","article-title":"Inverse Relationship Between Cerebrovascular Lesions and Severity of Lewy Body Pathology in Patients with Lewy Body Diseases","volume":"69","author":"Ghebremedhin","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neurobiolaging.2021.04.029","article-title":"Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies","volume":"105","author":"Ferreira","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2016.07.003","article-title":"An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer\u2019s disease","volume":"13","author":"Sarro","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00702-021-02345-9","article-title":"Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases","volume":"128","author":"Jellinger","year":"2021","journal-title":"J. Neural Transm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.67.1.66","article-title":"White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer\u2019s disease, vascular dementia, and normal aging","volume":"67","author":"Barber","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2017.12.018","article-title":"White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson\u2019s disease with dementia, and Alzheimer\u2019s disease","volume":"385","author":"Joki","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_47","first-page":"1234","article-title":"Neuropathology of dementia in patients with Par-kinson\u2019s disease: A systematic review of autopsy studies","volume":"90","author":"Smith","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neulet.2010.09.036","article-title":"Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia","volume":"486","author":"Fujishiro","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","article-title":"Concomitant pathologies among a spectrum of parkinsonian disorders","volume":"20","author":"Dugger","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_50","first-page":"444","article-title":"The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders","volume":"8","author":"Irwin","year":"2018","journal-title":"J. Alzheimer\u2019s Dis. Park."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","article-title":"Neuropathology and molecular diagnosis of Synucleinopathies","volume":"16","author":"Koga","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awaa438","article-title":"The development and convergence of co-pathologies in Alzheimer\u2019s disease","volume":"144","author":"Robinson","year":"2021","journal-title":"Brain"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/alz.13704","article-title":"Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer\u2019s disease pathology","volume":"20","author":"Pillai","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","article-title":"Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies","volume":"72","author":"Gelpi","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00401-023-02657-y","article-title":"Distinct tau and alpha-synuclein molecular signatures in Alzheimer\u2019s disease with and without Lewy bodies and Parkinson\u2019s disease with dementia","volume":"147","author":"Deshayes","year":"2024","journal-title":"Acta Neuropathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.parkreldis.2019.02.011","article-title":"Neuropathological and genetic characteristics of a post-mortem series of cases with dementia with Lewy bodies clinically suspected of Creutzfeldt-Jakob\u2019s disease","volume":"63","author":"Geut","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/brain\/awae372","article-title":"Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer\u2019s disease and synucleinopathies","volume":"148","author":"Colloby","year":"2024","journal-title":"Brain"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neurobiolaging.2018.07.005","article-title":"Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer\u2019s disease pathology","volume":"71","author":"Steenwijk","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"103714","DOI":"10.1016\/j.nicl.2024.103714","article-title":"Posterior hippocampal sparing in Lewy body disorders with Alzheimer\u2019s copathology: An in vivo MRI study","volume":"45","author":"Cohen","year":"2024","journal-title":"NeuroImage Clin."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/RLU.0000000000005081","article-title":"Identifying Mixed Dementia with Lewy Bodies and Alzheimer Disease Using Multitracer PET Imaging","volume":"49","author":"Li","year":"2024","journal-title":"Clin. Nucl. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/brain\/awn298","article-title":"Medial temporal lobe atrophy on MRI differentiates Alzheimer\u2019s disease from dementia with Lewy bodies and vascular cognitive impairment: A prospective study with pathological verification of diagnosis","volume":"132","author":"Burton","year":"2008","journal-title":"Brain"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/brain\/aww005","article-title":"MRI visual rating scales in the diagnosis of dementia: Evaluation in 184 post-mortem confirmed cases","volume":"139","author":"Harper","year":"2016","journal-title":"Brain"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neurobiolaging.2014.07.005","article-title":"Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies","volume":"36","author":"Nedelska","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e846","DOI":"10.1212\/WNL.0000000000201579","article-title":"Cross-sectional Associations of \u03b2-Amyloid, Tau, and Cerebrovascular Biomarkers with Neurodegeneration in Probable Dementia with Lewy Bodies","volume":"100","author":"Ferreira","year":"2023","journal-title":"Neurology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"fcae290","DOI":"10.1093\/braincomms\/fcae290","article-title":"Cerebrovascular and Alzheimer\u2019s disease biomarkers in dementia with Lewy bodies and other dementias","volume":"6","author":"Rennie","year":"2024","journal-title":"Brain Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13195-025-01678-x","article-title":"Association of Alzheimer\u2019s and Lewy body disease pathology with basal forebrain volume and cognitive impairment","volume":"17","author":"Schumacher","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"102062","DOI":"10.1016\/j.nicl.2019.102062","article-title":"Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer\u2019s disease pathology: An 123I-FP-CIT SPECT study","volume":"25","author":"Joling","year":"2020","journal-title":"NeuroImage Clin."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awae352","article-title":"Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer\u2019s and Lewy body disease","volume":"148","author":"Duong","year":"2024","journal-title":"Brain"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40478-024-01786-z","article-title":"Neuroinflammation is associated with Alzheimer\u2019s disease co-pathology in dementia with Lewy bodies","volume":"12","author":"Geut","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3233\/JAD-210365","article-title":"Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies","volume":"83","author":"Tesi","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2016-313775","article-title":"Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies","volume":"88","author":"Lemstra","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"107255","DOI":"10.1016\/j.parkreldis.2024.107255","article-title":"The effect of Amyloid and Tau Co-pathology on disease progression in Lewy body dementia: A systematic review","volume":"131","author":"Tan","year":"2024","journal-title":"Park. Relat. Disord."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/WCO.0000000000001173","article-title":"Clinical trials in dementia with Lewy bodies: The evolving concept of co-pathologies, patient selection and biomarkers","volume":"36","author":"Gibson","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13024-021-00503-x","article-title":"TDP-43 pathology in Alzheimer\u2019s disease","volume":"16","author":"Meneses","year":"2021","journal-title":"Mol Neurodegener"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","article-title":"Updated TDP-43 in Alzheimer\u2019s disease staging scheme","volume":"131","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000287952","article-title":"Caspase-Cleaved Transactivation Response DNA-Binding Protein 43 in Parkinson\u2019s Disease and Dementia with Lewy Bodies","volume":"7","author":"Kokoulina","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Shen, L., Wang, C., Chen, L., Leung, K.L., Lo, E., Lakso, M., and Wong, G. (2020). TDP-1\/TDP-43 potentiates human \u03b1-Synuclein (HASN) neurodegeneration in Caenorhabditis elegans. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165876"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00401-010-0731-9","article-title":"Effect of topographical distribution of \u03b1-synuclein pathology on TDP-43 accumulation in Lewy body disease","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40478-014-0088-8","article-title":"Pathological alpha-synuclein propagates through neural networks","volume":"2","author":"Nonaka","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7150\/ijbs.7.234","article-title":"TDP-43 Potentiates Alpha-synuclein Toxicity to Dopaminergic Neurons in Transgenic Mice","volume":"7","author":"Tian","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1007\/s00415-013-7101-1","article-title":"Prominent psychiatric symptoms in patients with Parkinson\u2019s disease and concomitant argyrophilic grain disease","volume":"260","author":"Gelpi","year":"2013","journal-title":"J. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/neup.12208","article-title":"Medial temporal regional argyrophilic grain as a possible important factor affecting dementia in Parkinson\u2019s disease","volume":"35","author":"Homma","year":"2015","journal-title":"Neuropathology"},{"key":"ref_84","first-page":"695","article-title":"Autopsy case of Lewy body dementia associated with abundant argyrophilic grains","volume":"57","author":"Oshima","year":"2005","journal-title":"No Shinkei Brain Nerve"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/13554794.2021.1921220","article-title":"An autopsy case of corticobasal syndrome with pure diffuse Lewy Body Disease","volume":"27","author":"Ichinose","year":"2021","journal-title":"Neurocase"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1212\/WNL.0000000000005828","article-title":"Diffuse Lewy body disease manifesting as corticobasal syndrome: A rare form of Lewy body disease","volume":"91","author":"Kasanuki","year":"2018","journal-title":"Neurology"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Kaiserov\u00e1, M., Men\u0161\u00edkov\u00e1, K., Tu\u010dkov\u00e1, L., Hlu\u0161t\u00edk, P., and Ka\u0148ovsk\u00fd, P. (2021). Case Report: Concomitant Alzheimer\u2019s and Lewy-Related Pathology Extending the Spectrum of Underlying Pathologies of Corticobasal Syndrome. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.742042"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e13112","DOI":"10.1111\/bpa.13112","article-title":"Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer\u2019s disease, progressive supranuclear palsy, and dementia with Lewy bodies","volume":"33","author":"Montalbano","year":"2022","journal-title":"Brain Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"M\u00fcller, S.J., Khadhraoui, E., Hansen, N., Jamous, A., Langer, P., Wiltfang, J., Riedel, C.H., Bouter, C., van Riesen, C., and Maass, F. (2023). Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson\u2019s disease on MRI. BMC Neurol., 23.","DOI":"10.1186\/s12883-023-03151-4"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00702-003-0824-x","article-title":"Prevalence of vascular lesions in Dementia with Lewy Bodies. A postmortem study","volume":"110","author":"Jellinger","year":"2003","journal-title":"J. Neural Transm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","article-title":"Neuroimaging standards for research into small vessel disease\u2014Advances since 2013","volume":"22","author":"Duering","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Chen, T.-Y., Chan, P.-C., Tsai, C.-F., Wei, C.-Y., and Chiu, P.-Y. (2022). White matter hyperintensities in dementia with Lewy bodies are associated with poorer cognitive function and higher dementia stages. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.935652"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1440-1789.2006.00699.x","article-title":"Vascular complications in dementia with Lewy bodies: A postmortem study","volume":"26","author":"Isojima","year":"2006","journal-title":"Neuropathology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"8312346","DOI":"10.1155\/2018\/8312346","article-title":"Metabolic risk factors of Alzheimer\u2019s disease, dementia with Lewy bodies, and normal elderly: A population-based study","volume":"2018","author":"Cheng","year":"2018","journal-title":"Behav. Neurol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Ren, Z., Gan, J., Chen, Z., Shi, Z., Liu, S., Lu, H., Zhang, G., and Ji, Y. (2025). Cerebral microbleeds: Prevalence and relationship to clinical features in cognitive impairment with lewy body disease. BMC Neurol., 25.","DOI":"10.1186\/s12883-025-04181-w"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3174\/ajnr.A4337","article-title":"Cerebral Microbleeds in Patients with Dementia with Lewy Bodies and Parkinson Disease Dementia","volume":"36","author":"Kim","year":"2015","journal-title":"Am. J. Neuroradiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2022.10.009","article-title":"Cerebral microbleeds in dementia with Lewy bodies","volume":"104","author":"Chin","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00415-020-09736-0","article-title":"Microbleeds in dementia with Lewy bodies","volume":"267","author":"Donaghy","year":"2020","journal-title":"J. Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2023.11.006","article-title":"Prevalence of cerebral microbleeds in Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease dementia: A systematic review and meta-analysis","volume":"134","author":"Chin","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Abdi, A., Alipour, M., Ghanikolahloo, M., Magsudy, A., HojjatiPour, F., Gholamrezanezhad, A., Ilaghi, M., Anjomrooz, M., Sayehmiri, F., and Hajibeygi, R. (2025). Comparative analysis of white matter signal alterations in dementia with Lewy bodies and Alzheimer\u2019s disease: A systematic review and meta-analysis. Front. Radiol., 5.","DOI":"10.3389\/fradi.2025.1554345"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"fcaf173","DOI":"10.1093\/braincomms\/fcaf173","article-title":"Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum","volume":"7","author":"Jerele","year":"2025","journal-title":"Brain Commun."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00401-017-1738-2","article-title":"Parietal white matter lesions in Alzheimer\u2019s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease","volume":"134","author":"McAleese","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/STROKEAHA.121.032608","article-title":"Neuropathology of Vascular Brain Health: Insights from Ex Vivo Magnetic Resonance Imaging\u2013Histopathology Studies in Cerebral Small Vessel Disease","volume":"53","author":"Arfanakis","year":"2022","journal-title":"Stroke"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Saji, N., Kinjo, Y., Murotani, K., Niida, S., Takeda, A., and Sakurai, T. (2024). High pulse wave velocity is associated with enlarged perivascular spaces in dementia with Lewy bodies. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-64984-8"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jocn.2022.02.038","article-title":"Lewy body dementia is associated with an increased risk of atrial fibrillation: A case-control study","volume":"99","author":"Nogueira","year":"2022","journal-title":"J. Clin. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e70053","DOI":"10.1002\/trc2.70053","article-title":"Sick sinus syndrome and high-degree atrioventricular block in dementia with Lewy bodies and other dementia subtypes: A study of \u2248 73,000 patients with dementia","volume":"11","author":"Heyman","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/jnnp.2003.023812","article-title":"Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions","volume":"75","author":"Kenny","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1007\/s11357-024-01479-4","article-title":"High prevalence of atrial conduction abnormalities in Lewy body disease-a marker of cardiac complications?","volume":"47","author":"Javanshiri","year":"2025","journal-title":"Geroscience"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10286-023-00933-1","article-title":"Orthostatic hypotension in dementia with Lewy bodies: A meta-analysis of prospective studies","volume":"33","author":"Isik","year":"2023","journal-title":"Clin. Auton. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1038\/s41440-024-01829-x","article-title":"Postprandial hypotension is more common than orthostatic hypotension in older adults with dementia with lewy bodies: A cross-sectional study","volume":"47","author":"Isik","year":"2024","journal-title":"Hypertens. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0028-3843(14)60005-0","article-title":"The influence of vascular risk factors on the survival rate of patients with dementia with Lewy bodies and Alzheimer disease","volume":"44","author":"Magierski","year":"2010","journal-title":"Neurol. i Neurochir. Polska"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3233\/JAD-190485","article-title":"Cardiovascular Disease, Diabetes Mellitus, and Hypertension in Lewy Body Disease: A Comparison with Other Dementia Disorders","volume":"71","author":"Javanshiri","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3233\/JAD-160847","article-title":"Effect of Vascular Risk Factors on the Progression of Mild Alzheimer\u2019s Disease and Lewy Body Dementia","volume":"56","author":"Bergland","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"fcad346","DOI":"10.1093\/braincomms\/fcad346","article-title":"Association of cardiovascular disease management drugs with Lewy body dementia: A case\u2013control study","volume":"6","author":"Scholz","year":"2023","journal-title":"Brain Commun."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12944-024-02032-0","article-title":"Elevated serum LDL-C increases the risk of Lewy body dementia: A two-sample mendelian randomization study","volume":"23","author":"Liu","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Fu, Q., Pan, G., Yu, Q., Liu, Z., Shen, T., Ma, X., and Jiang, L. (2024). Exploring the causal effects of serum lipids and lipidomes on lewy body dementia: A Mendelian randomization study. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1456005"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3233\/JAD-240267","article-title":"Undetected Association Between Fatty Acids and Dementia with Lewy Bodies: A Bidirectional Two-Sample Mendelian Randomization Study","volume":"100","author":"Zhai","year":"2024","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.parkreldis.2021.06.016","article-title":"Coincident parkinsonism and myasthenia gravis: A case series","volume":"89","author":"Alshaikh","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5692\/clinicalneurol.cn-001204","article-title":"A case of dementia with Lewy bodies and Hashimoto en-cephalopathy successfully treated with immunotherapy","volume":"59","author":"Ikawa","year":"2019","journal-title":"Rinsho Shinkeigaku"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00415-023-12145-8","article-title":"Differentiating an-ti-IgLON5 disease and Lewy body dementia: A systematic review","volume":"271","author":"McWilliam","year":"2024","journal-title":"J. Neurol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/gps.342","article-title":"Dementia with Lewy bodies in Down\u2019s syndrome","volume":"16","author":"Simard","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1007\/s00415-021-10778-1","article-title":"Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus","volume":"269","author":"Sakurai","year":"2021","journal-title":"J. Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40520-025-02958-0","article-title":"Clinical implication of anemia in older patients with dementia with lewy bodies","volume":"37","author":"Karismaz","year":"2025","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Nakamura, S., Sugawara, H., Asada, R., Hatanaka, A., and Hori, H. (2024). Bipolar disorder and Lewy body dementia: Case report and literature review. Front. Psychiatry, 15.","DOI":"10.3389\/fpsyt.2024.1409027"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jagp.2024.04.005","article-title":"Adult Attention Deficit-Hyperactivity Disorder is associated with Lewy Body Disease and Cognitive Impairment: A prospective cohort Study With 15-year Follow-Up","volume":"32","author":"Golimstok","year":"2024","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e3257","DOI":"10.1212\/WNL.0000000000010943","article-title":"\u03b2-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies","volume":"95","author":"Ferreira","year":"2020","journal-title":"Neurology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/mds.25048","article-title":"Brain amyloid and cognition in Lewy body diseases","volume":"27","author":"Gomperts","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bpa.12182","article-title":"Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias","volume":"25","author":"Howlett","year":"2014","journal-title":"Brain Pathol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2008.12.008","article-title":"Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics","volume":"34","author":"Maetzler","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13195-019-0537-5","article-title":"Amyloid-\u03b2 peptides in cerebrospinal fluid of patients with dementia with Lewy bodies","volume":"11","author":"Scheltens","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1093\/brain\/awae203","article-title":"Clinical and diagnostic implications of Alzheimer\u2019s disease copathology in Lewy body disease","volume":"147","author":"Barba","year":"2024","journal-title":"Brain"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","article-title":"Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: A retrospective analysis","volume":"16","author":"Irwin","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1212\/WNL.0000000000009763","article-title":"Subtypes of dementia with Lewy bodies are associated with \u03b1-synuclein and tau distribution","volume":"95","author":"Ferman","year":"2020","journal-title":"Neurology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1002\/alz.14039","article-title":"In vivo detection of Alzheimer\u2019s and Lewy body disease concurrence: Clinical implications and future perspectives","volume":"20","author":"Baiardi","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e209418","DOI":"10.1212\/WNL.0000000000209418","article-title":"Association of Plasma Amyloid, P-Tau, GFAP, and NfL with CSF, Clinical, and Cognitive Features in Patients with Dementia with Lewy Bodies","volume":"102","author":"Bolsewig","year":"2024","journal-title":"Neurology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e1855","DOI":"10.1212\/WNL.0000000000011699","article-title":"Cognitive Profile and Markers of Alzheimer Disease\u2013Type Pathology in Patients with Lewy Body Dementias","volume":"96","author":"Howard","year":"2021","journal-title":"Neurology"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3233\/JAD-201187","article-title":"Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer\u2019s Disease Pathology","volume":"80","author":"Ryman","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000354670","article-title":"The significance of alpha-synuclein, amyloid-beta and tau pathologies in Parkinson\u2019s disease progression and related dementia","volume":"13","author":"Compta","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"102333","DOI":"10.1016\/j.nicl.2020.102333","article-title":"The combined effect of amyloid-\u03b2 and tau biomarkers on brain atrophy in dementia with Lewy bodies","volume":"27","author":"Abdelnour","year":"2020","journal-title":"NeuroImage: Clin."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1177\/13872877251351220","article-title":"Concurrent Alzheimer\u2019s disease pathologies in Lewy body diseases affect cognition and glucose metabolism in the posterior cingulate gyrus: A multimodal PET study","volume":"106","author":"Nakamura","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","article-title":"The limbic and neocortical contribution of a-synuclein, tau, and amyloid \u00df to disease du-ration in dementia with Lewy bodies","volume":"14","author":"Ferman","year":"2018","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00401-003-0750-x","article-title":"Age-associated prevalence and risk factors of Lewy body pathology in a general population: The Hisayama study","volume":"106","author":"Wakisaka","year":"2003","journal-title":"Acta Neuropathol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1007\/s00415-020-09718-2","article-title":"TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional\/diffuse Lewy body disease","volume":"267","author":"Buciuc","year":"2020","journal-title":"J. Neurol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00401-008-0347-5","article-title":"Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease","volume":"115","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jns.2015.03.046","article-title":"Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism","volume":"353","author":"Park","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000351423","article-title":"Prevalence and Clinical Implication of Microbleeds in Dementia with Lewy Bodies in Comparison with Microbleeds in Alzheimer\u2019s Disease","volume":"3","author":"Fukui","year":"2013","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/01.JGP.0000236596.56982.1c","article-title":"Progression of White Matter Hyperintensities in Alzheimer Disease, Dementia With Lewy Bodies, and Parkinson Disease Dementia: A Comparison with Normal Aging","volume":"14","author":"Burton","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000343480","article-title":"White Matter Hyperintensities in Mild Lewy Body Dementia","volume":"2","author":"Oppedal","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord. Extra"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e1807","DOI":"10.1212\/WNL.0000000000008377","article-title":"APOE \u03b54, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia","volume":"93","author":"Mirza","year":"2019","journal-title":"Neurology"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(17)30400-3","article-title":"Investigating the genetic architecture of dementia with Lewy bodies: A two-stage genome-wide association study","volume":"17","author":"Guerreiro","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Rongve, A., Witoelar, A., Ruiz, A., Athanasiu, L., Abdelnour, C., Clarimon, J., Heilmann-Heimbach, S., Hern\u00e1ndez, I., Moreno-Grau, S., and de Rojas, I. (2019). GBA and APOE \u03b54 associate with sporadic dementia with Lewy bodies in European genome wide association study. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-43458-2"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2016.06.004","article-title":"Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies","volume":"94","author":"Geiger","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE epsilon4 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies","volume":"23","author":"Bras","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e70370","DOI":"10.1111\/cns.70370","article-title":"Identification of Common Brain Protein and Genetic Loci Between Parkinson\u2019s Disease and Lewy Body Dementia","volume":"31","author":"Jia","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/gps.381","article-title":"The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer\u2019s disease","volume":"16","author":"Ballard","year":"2001","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Larsson, V., Torisson, G., Londos, E., and Toft, M. (2018). Relative survival in patients with dementia with Lewy bodies and Parkinson\u2019s disease dementia. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202044"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.trci.2019.08.005","article-title":"Alzheimer\u2019s disease pathology explains association between dementia with Lewy bodies and APOE-\u00ce\u00b54\/TOMM40 long poly-T repeat allele variants","volume":"5","author":"Prokopenko","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/brain\/awu119","article-title":"Convergence of pathology in dementia with Lewy bodies and Alzheimer\u2019s disease: A role for the novel interaction of alpha-synuclein and presenilin 1 in disease","volume":"137","author":"Winslow","year":"2014","journal-title":"Brain"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Guo, P., Gong, W., Li, Y., Liu, L., Yan, R., Wang, Y., Zhang, Y., and Yuan, Z. (2022). Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer\u2019s disease and Parkinson\u2019s disease: A large-scale multi-trait association analysis. BMC Med., 20.","DOI":"10.1186\/s12916-022-02404-2"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-020-02199-7","article-title":"ADNC-RS, a clinical-genetic risk score, predicts Alzheimer\u2019s pathology in autopsy-confirmed Parkinson\u2019s disease and Dementia with Lewy bodies","volume":"140","author":"Dai","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Higginbotham, L., Shantaraman, A., Guo, Q., Fox, E.J., Bagchi, P., Wu, F., Lah, J.J., Levey, A.I., and Seyfried, N.T. (2025). Multiplex pro-teomics of Lewy body dementia reveals cerebrospinal fluid biomarkers of disease pathology and progression. bioRxiv, 2025.06.10.658994. Available online: https:\/\/www.biorxiv.org\/content\/10.1101\/2025.06.10.658994v1.","DOI":"10.1101\/2025.06.10.658994"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1017\/neu.2025.15","article-title":"Systematic review of differentially abundant proteins in people with Lewy body dementia","volume":"37","author":"Farr","year":"2025","journal-title":"Acta Neuropsychiatr."},{"key":"ref_164","first-page":"e14375","article-title":"Proteomic signatures of Alzheimer\u2019s disease and Lewy body dementias: A comparative analysis","volume":"21","author":"Branca","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Alipour-Haris, G., Armstrong, M.J., Sullivan, J.L., Suryadevara, U., Rouhizadeh, M., and Brown, J.D. (2022). Suicidal Ideation and Suicide-Attempt-Related Hospitalizations among People with Alzheimer\u2019s Disease (AD) and AD-Related Dementias in the United States during 2016\u20132018. J. Clin. Med., 11.","DOI":"10.3390\/jcm11040943"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/alz.12390","article-title":"Suicide risk in first year after dementia diagnosis in older adults","volume":"18","author":"Schmutte","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamaneurol.2022.3094","article-title":"Risk of Suicide After Dementia Diagnosis","volume":"79","author":"Alothman","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref_168","first-page":"e70144","article-title":"It is time to share Alzheimer biomarker results in dementia with Lewy bodies","volume":"17","author":"Armstrong","year":"2025","journal-title":"Alzheimer\u2019s Dement. Diagn. Assess. Dis. Monit."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3233\/JAD-150731","article-title":"Diagnostic value of cerebrospinal fluid biomarkers (phospho-tau181, total-tau, Abeta42, and Abeta40) in prodromal stage of Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"51","author":"Bousiges","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13195-020-00684-5","article-title":"Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alz-heimer\u2019s disease and dementia with Lewy bodies from the prodromal stage","volume":"12","author":"Bousiges","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"ref_171","first-page":"738","article-title":"Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies","volume":"28","author":"Hansson","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JAD-160322","article-title":"Cerebrospinal Fluid Alzheimer\u2019s Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort","volume":"54","author":"Aarsland","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000500567","article-title":"In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy Bodies","volume":"47","author":"Paraskevas","year":"2019","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00002093-200101000-00005","article-title":"Clinical and Pathologic Features of Two Groups of Patients with Dementia With Lewy Bodies: Effect of Coexisting Alzheimer-Type Lesion Load","volume":"15","author":"Hachinski","year":"2001","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"ref_175","first-page":"109","article-title":"CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies","volume":"91","author":"Abdelnour","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/mds.26668","article-title":"Alzheimer\u2019s disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia","volume":"31","author":"Abdelnour","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.parkreldis.2022.07.008","article-title":"The relationship between plasma biomarkers and amyloid PET in dementia with Lewy bodies","volume":"101","author":"Donaghy","year":"2022","journal-title":"Park. Relat. Disord."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.24825","article-title":"AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies","volume":"81","author":"Kantarci","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cca.2019.04.078","article-title":"Parkinson\u2019s and Lewy body dementia CSF biomarkers","volume":"495","author":"Parnetti","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13024-025-00868-3","article-title":"Alpha-synuclein seeding amplification assays in Lewy body dementia: A brief review","volume":"20","author":"Bregendahl","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/acn3.52034","article-title":"Multiple biomarkers improve diagnostic accuracy across Lewy body and Alzheimer\u2019s disease spectra","volume":"11","author":"Plastini","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Morimoto, S., Takao, M., Hatsuta, H., Nishina, Y., Komiya, T., Sengoku, R., Nakano, Y., Uchino, A., Sumikura, H., and Saito, Y. (2017). Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer\u2019s disease: An autopsy-confirmed study. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0171524"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-025-01685-y","article-title":"Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer\u2019s pathophysiological biomarkers","volume":"17","author":"Goossens","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","article-title":"Head-to-head comparison of 8 plasma amyloid-beta 42\/40 assays in Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41582-022-00665-2","article-title":"Blood phospho-tau in Alzheimer disease: Analysis, interpretation, and clinical utility","volume":"18","author":"Karikari","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamaneurol.2021.4222","article-title":"Association of Plasma p-tau181 and p-tau231 Concentrations with Cognitive Decline in Patients with Probable Dementia with Lewy Bodies","volume":"79","author":"Gonzalez","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1136\/jnnp-2021-327370","article-title":"Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer\u2019s disease: A focused review on recent advances","volume":"92","author":"Chong","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","article-title":"Plasma p-tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline","volume":"140","author":"Rodriguez","year":"2020","journal-title":"Acta Neuropathol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","article-title":"Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum","volume":"144","author":"Moscoso","year":"2020","journal-title":"Brain"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-022-02408-5","article-title":"Plasma biomarkers for Alzheimer\u2019s Disease in relation to neuropathology and cognitive change","volume":"143","author":"Smirnov","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"ana.27288","DOI":"10.1002\/ana.27288","article-title":"Blood alpha-synuclein separates Parkinson\u2019s disease from dementia with Lewy bodies","volume":"16","author":"Kannarkat","year":"2025","journal-title":"Ann. Neurol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/00048674231177219","article-title":"Tau in dementia with Lewy bodies","volume":"58","author":"Chin","year":"2024","journal-title":"Aust. New Zealand J. Psychiatry"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/acn3.51768","article-title":"Plasma GFAP associates with secondary Alzheimer\u2019s pathology in Lewy body disease","volume":"10","author":"Cousins","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/mds.28370","article-title":"Plasma phospho-tau identifies Alzheimer\u2019s co-pathology in patients with Lewy body disease","volume":"36","author":"Hall","year":"2021","journal-title":"Mov. Disord."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.28994","article-title":"A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer\u2019s Disease","volume":"37","author":"Thomas","year":"2022","journal-title":"Mov. Disord."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/brain\/awaf003","article-title":"Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder","volume":"148","author":"Delva","year":"2025","journal-title":"Brain"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/alz.13653","article-title":"Plasma biomarkers of Alzheimer\u2019s disease in the continuum of dementia with Lewy bodies","volume":"20","author":"Przybelski","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/WCO.0000000000000958","article-title":"Update on neuroimaging in non-Alzheimer\u2019s disease dementia: A focus on the Lewy body disease spectrum","volume":"34","author":"Scamarcia","year":"2021","journal-title":"Curr. Opin. Neurol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/acn3.51183","article-title":"Tau pathology associates with in vivo cortical thinning in Lewy body disorders","volume":"7","author":"Spotorno","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jagp.2019.12.009","article-title":"Amyloid Imaging and Longitudinal Clinical Progression in Dementia with Lewy Bodies","volume":"28","author":"Donaghy","year":"2020","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"e1916439","DOI":"10.1001\/jamanetworkopen.2019.16439","article-title":"Association of Longitudinal \u03b2-Amyloid Accumulation Determined by Positron Emission Tomography with Clinical and Cognitive Decline in Adults with Probable Lewy Body Dementia","volume":"2","author":"Nedelska","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2016.3338","article-title":"Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases","volume":"73","author":"Gomperts","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.30055","article-title":"(18)F-florzolotau PET imaging unveils tau pathology in dementia with Lewy bodies","volume":"40","author":"Tang","year":"2025","journal-title":"Mov. Disord."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41531-025-00944-x","article-title":"Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer\u2019s disease copathologies","volume":"11","author":"Mak","year":"2025","journal-title":"npj Park. Dis."},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Amin, J., Erskine, D., Donaghy, P.C., Surendranathan, A., Swann, P., Kunicki, A.P., Boche, D., Holmes, C., McKeith, I.G., and O\u2019Brien, J.T. (2022). Inflammation in dementia with Lewy bodies. Neurobiol. Dis., 168.","DOI":"10.1016\/j.nbd.2022.105698"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Camporesi, E., Nilsson, J., Brinkmalm, A., Becker, B., Ashton, N.J., Blennow, K., and Zetterberg, H. (2020). Fluid Biomarkers for Synaptic Dysfunction and Loss. Biomark. Insights, 15.","DOI":"10.1177\/1177271920950319"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00702-022-02467-8","article-title":"Fluid markers of synapse degeneration in synucleinopathies","volume":"129","author":"Belbin","year":"2022","journal-title":"J. Neural Transm."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","article-title":"The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease","volume":"12","author":"Zetterberg","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"fcaa142","DOI":"10.1093\/braincomms\/fcaa142","article-title":"TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients","volume":"2","author":"Tran","year":"2020","journal-title":"Brain Commun."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3233\/JAD-210342","article-title":"Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies","volume":"82","author":"Pilotto","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-020-00388-2","article-title":"Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: A proteomic approach","volume":"15","author":"Vergouw","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/alz.13447","article-title":"Identifying individuals with non-Alzheimer\u2019s disease co-pathologies: A precision medicine approach to clinical trials in spo-radic Alzheimer\u2019s disease","volume":"20","author":"Tosun","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1017\/cjn.2022.34","article-title":"Current Concepts of Mixed Pathologies in Neurodegenerative Diseases","volume":"50","author":"Forrest","year":"2022","journal-title":"Can. J. Neurol. Sci.\/J. Can. des Sci. Neurol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"e1821","DOI":"10.1212\/WNL.0000000000007315","article-title":"Pro-gressive parkinsonism in older adults is related to the burden of mixed brain pathologies","volume":"92","author":"Buchman","year":"2019","journal-title":"Neurology"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/B978-0-323-85538-9.00012-2","article-title":"Mixed pathology as a rule, not exception: Time to reconsider disease nosology","volume":"192","author":"Chu","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"ref_218","first-page":"35","article-title":"Prevalence of concomitant pathologies in Parkinson\u2019s disease: Implications for prognosis, diagnosis, and insights into common pathogenic mechanisms","volume":"14","author":"Walker","year":"2024","journal-title":"J. Park. Dis."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Kulichikhin, K.Y., Malikova, O.A., Zobnina, A.E., Zalutskaya, N.M., and Rubel, A.A. (2023). Interaction of Proteins Involved in Neuronal Proteinopathies. Life, 13.","DOI":"10.3390\/life13101954"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13195-018-0356-0","article-title":"Improving the identification of dementia with Lewy bodies in the context of an Alzheimer\u2019s-type dementia","volume":"10","author":"Thomas","year":"2018","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_221","first-page":"1155","article-title":"Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer\u2019s Disease to Parkinson\u2019s Disease","volume":"12","author":"Weinshel","year":"2022","journal-title":"J. Park. Dis."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/7674\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:21Z","timestamp":1760034381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/16\/7674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":222,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26167674"],"URL":"https:\/\/doi.org\/10.3390\/ijms26167674","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}